Abstract:Pulmonary senescence is accelerated by unresolved DNA damage response, underpinning susceptibility to pulmonary fibrosis. Recently it was reported that the SARS-Cov-2 viral infection induces acute pulmonary epithelial senescence followed by fibrosis, although the mechanism remains unclear. Here, we examine roles of alveolar epithelial stem cell senescence and senescence-associated differentiation disorders in pulmonary fibrosis, exploring the mechanisms mediating and preventing pulmonary fibrogenic crisis. Notably, the TGF-β signalling pathway mediates alveolar epithelial stem cell senescence by mechanisms involving suppression of the telomerase reverse transcriptase gene in pulmonary fibrosis. Alternatively, telomere uncapping caused by stress-induced telomeric shelterin protein TPP1 degradation mediates DNA damage response, pulmonary senescence and fibrosis. However, targeted intervention of cellular senescence disrupts pulmonary remodelling and fibrosis by clearing senescent cells using senolytics or preventing senescence using telomere dysfunction inhibitor (TELODIN). Studies indicate that the development of senescence-associated differentiation disorders is reprogrammable and reversible by inhibiting stem cell replicative senescence in pulmonary fibrosis, providing a framework for targeted intervention of the molecular mechanisms of alveolar stem cell senescence and pulmonary fibrosis. Abbreviations: DPS, developmental programmed senescence; IPF, idiopathic pulmonary fibrosis; OIS, oncogene-induced replicative senescence; SADD, senescence-associated differentiation disorder; SALI, senescence-associated low-grade inflammation; SIPS, stress-induced premature senescence; TERC, telomerase RNA component; TERT, telomerase reverse transcriptase; TIFs, telomere dysfunction-induced foci; TIS, therapy-induced senescence; VIS, virus-induced senescence.

[Progress on Correlation Between Cell Senescence and Idiopathic Pulmonary Fibrosis].

Advances in cellular senescence in idiopathic pulmonary fibrosis (Review)

Senescent AECⅡ and the Implication for Idiopathic Pulmonary Fibrosis Treatment.

Telomere Dysfunction in Idiopathic Pulmonary Fibrosis

Senescent lung-resident mesenchymal stem cells drive pulmonary fibrogenesis through FGF-4/FOXM1 axis

Aged alveolar epithelium contributes to inflammaging and reduced stem cell function in the lung

Cellular Senescence in Lung Fibrosis

Prolonged WNT/ß-catenin signaling induces cellular senescence in aging and pulmonary fibrosis

A Troy Horse in Pulmonary Fibrosis

Cellular and Molecular Mechanisms in Idiopathic Pulmonary Fibrosis

Molecular Mechanisms of Alveolar Epithelial Stem Cell Senescence and Senescence-Associated Differentiation Disorders in Pulmonary Fibrosis

Role of Cellular Senescence in Inflammatory Lung Diseases

Biomarkers of cellular senescence in idiopathic pulmonary fibrosis

Potential Role of Cellular Senescence in Asthma

Mitochondrial dysfunction contributes to the senescent phenotype of IPF lung fibroblasts

Epithelial cell senescence induces pulmonary fibrosis through Nanog-mediated fibroblast activation

Telomeres, Telomerases and Idopathic Pulmonary Fibrosis

Progress in Cellular Senescence and Organ Fibrosis

Latest progress on the molecular mechanisms of idiopathic pulmonary fibrosis

Extracellular HSP90α Promotes Cellular Senescence by Modulating TGF ‐β Signaling in Pulmonary Fibrosis

Idiopathic pulmonary fibrosis beyond the lung: understanding disease mechanisms to improve diagnosis and management